Health Affairs, 28, no. 5 (2009): w832-w841 (Published online 30 July 2009) doi: 10.1377/hlthaff.28.5.w832 © 2009 by Project HOPE	New Online   Senate Health Reform Bill   Rewarding Providers   Public Option Policy Brief   Health Reform & Abortion   Delivery System Reform

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Google Scholar Articles by Outterson, K. Articles by Kesselheim, A. S. PubMed PubMed Citation Articles by Outterson, K. Articles by Kesselheim, A. S. Related Collections Health Reform Managed Care - Medicare Medicare Business Of Health Pharmaceuticals Health Spending Consumer Issues

Web Exclusives

How Medicare Could Get Better Prices On Prescription Drugs

Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform effort. Currently, the "noninterference" provision prevents the government from negotiating drug prices on behalf of Medicare Part D prescription drug plans. Commonly considered reform proposals borrow ideas from Medicaid, either through returning dual eligibles to Medicaid drug pricing or by imposing mandatory rebates across the Part D population. We examine a menu of other options, including value-based pricing; expansion of generic and therapeutically equivalent substitution; increased formulary diversity; importation; and limited antitrust waivers. These latter options may reduce federal spending without direct government price negotiations.

                      What's this?